Does ovine uterus extract improve fertility or reproductive health?

There is currently no human clinical evidence demonstrating that ovine uterus extract improves fertility or reproductive outcomes. While the extract theoretically contains uterine growth factors such as IGF-1 and TGF-β, no randomized controlled trials have measured endpoints like ovulation rate, implantation success, or hormonal balance in human subjects. Claims linking this ingredient to reproductive support remain entirely theoretical.

Is ovine uterus extract safe to take?

The safety of ovine uterus extract has not been established in human studies, and no regulatory agency has set approved dosage guidelines. Primary concerns include allergic reactions to sheep-derived proteins and theoretical prion disease risk if tissue sourcing and processing standards are inadequate. Until rigorous safety trials are conducted, use carries unknown risk, particularly for immunocompromised individuals or those with animal protein allergies.

What is ovine uterus extract made from?

Ovine uterus extract is derived from the uterine tissue of domestic sheep (Ovis aries), typically processed through freeze-drying or lyophilization to concentrate tissue components. The resulting material theoretically retains uterine-specific proteins, glycosaminoglycans, phospholipids, and endogenous growth factors present in sheep uterine tissue. Quality and composition vary significantly between manufacturers, and no standardized extract specifications exist.

Can ovine uterus extract increase estrogen or progesterone levels?

No human studies have measured the effect of ovine uterus extract on circulating estrogen or progesterone levels. Uterine tissue contains estrogen and progesterone receptors and responds to these hormones, but it is unclear whether orally consumed uterine extract proteins survive digestion intact enough to exert any hormonal influence. Any claimed effect on sex hormone levels is speculative and unsupported by measurable clinical data.

How does ovine uterus extract differ from bovine uterus extract?

Both ovine (sheep) and bovine (cow) uterus extracts are glandular supplements theorized to contain similar classes of uterine-derived proteins, growth factors, and glycosaminoglycans, but they differ in species-specific protein sequences and glycosylation patterns. Neither has been studied in human clinical trials, and neither has an established evidence base for efficacy. The choice between them is largely commercial rather than clinically meaningful, as no head-to-head comparative studies exist.

What does current research show about the effectiveness of ovine uterus extract?

Clinical research on ovine uterus extract in humans is extremely limited, with no published human clinical trials to date. Available studies are restricted to animal models examining sheep pharmacokinetics and gestational physiology, which cannot reliably predict human outcomes. The lack of rigorous human evidence means claims about reproductive or health benefits remain theoretical rather than scientifically substantiated. Consumers should be aware that marketing claims often exceed the actual scientific support for this ingredient.

Who should avoid taking ovine uterus extract supplements?

Individuals who are pregnant, breastfeeding, or planning to become pregnant should consult a healthcare provider before use, as safety data in these populations is unavailable. People with a history of hormone-sensitive conditions, reproductive cancers, or those taking hormonal medications should exercise caution due to the unknown hormonal activity of this extract. Anyone with known allergies to sheep-derived products should avoid this ingredient entirely. Because evidence is lacking, those seeking evidence-based fertility support may benefit more from established medical interventions.

What is the typical dosage for ovine uterus extract, and is there a standard recommended amount?

There is no established safe or effective dosage for ovine uterus extract because human clinical trials determining appropriate dose ranges have never been conducted. Supplement manufacturers may list varying amounts, but these are generally based on traditional use rather than scientific optimization. Without regulatory guidance or clinical data, it is impossible to determine what dose, if any, would be appropriate or effective. Consumers should be cautious of products making specific dosage claims without supporting human research.

Ovine Uterus Extract (Ovis aries)

Ovine uterus extract is a glandular supplement derived from the uterine tissue of sheep (Ovis aries), theoretically containing uterine-specific proteins, glycosaminoglycans, and growth factors such as insulin-like growth factor-1 (IGF-1). No human clinical trials have been conducted to validate its proposed mechanisms or benefits in humans.

Category: Protein Evidence: 2/10 Tier: Emerging

Ovine Uterus Extract (Ovis aries) — Hermetica Encyclopedia

Origin & History

Ovine Uterus Extract is derived from the uterus of domestic sheep (Ovis aries), classified as an animal-derived glandular supplement. No specific therapeutic extraction methods are documented in available research; tissue processing methods mentioned include acidic hydrolysis used only for analytical purposes in pharmacokinetic studies.

Historical & Cultural Context

No historical or traditional medicine uses are documented in the available research for ovine uterus extract. Sources do not reference any traditional systems like Ayurveda or Traditional Chinese Medicine.

Health Benefits

• No clinically proven health benefits - no human clinical trials have been conducted on ovine uterus extract
• Animal model research only - available studies limited to sheep pharmacokinetics and gestational physiology (PMID: 3480283)
• No evidence for reproductive health support - despite theoretical connection to uterine tissue
• No documented immune or hormonal effects - research lacks any mechanism studies for extracts
• No traditional medicine validation - sources provide no historical use documentation

How It Works

Proponents hypothesize that ovine uterus extract delivers uterine-derived peptides, glycosaminoglycans, and growth factors—including IGF-1 and transforming growth factor-beta (TGF-β)—that may interact with endometrial growth factor receptors. Theoretically, these compounds could modulate prostaglandin synthesis pathways and influence uterine smooth muscle cell proliferation via paracrine signaling. However, oral bioavailability of intact bioactive peptides from glandular extracts is generally considered negligible due to proteolytic degradation in the gastrointestinal tract, and no receptor-binding studies in humans have been performed.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses exist for ovine uterus extract. Available research is limited to veterinary studies in sheep, including pharmacokinetics of antibiotics in uterine tissue and analysis of uterine secretions during gestation (PMID: 3480283), with no relevance to human supplementation.

Clinical Summary

No human clinical trials have been conducted on ovine uterus extract as a dietary supplement, making evidence-based conclusions impossible. Available pharmacokinetic data is limited to sheep models examining gestational physiology and uterine protein distribution (PMID: 3480283), which cannot be extrapolated to supplemental use in humans. The broader glandular therapy literature similarly lacks rigorous randomized controlled trials with measurable endpoints such as hormone levels, fertility outcomes, or menstrual cycle regulation. The current evidence base does not support any therapeutic claim for this ingredient in humans.

Nutritional Profile

Ovine uterus extract (Ovis aries) is a tissue-derived protein extract with a composition reflecting mammalian uterine tissue. Protein content is the primary macronutrient, estimated at 60-80% of dry weight, comprising structural proteins (collagen types I, III, and IV), contractile proteins (actin, myosin from myometrial smooth muscle), and extracellular matrix proteins (fibronectin, laminin). Collagen content is notable given the uterus's connective tissue density, contributing hydroxyproline (~13-14% of collagen amino acid content) and hydroxylysine as characteristic amino acids. Total amino acid profile includes glycine (~21% of collagen-derived protein), proline (~12%), alanine (~9%), and arginine, with branched-chain amino acids (leucine, isoleucine, valine) present from myometrial muscle protein fractions. Fat content is low, estimated at 5-15% dry weight, with phospholipids (phosphatidylcholine, phosphatidylethanolamine) dominating the lipid fraction as membrane-derived components; cholesterol present as a minor sterol fraction. Carbohydrate content is minimal (<5% dry weight), primarily as glycosaminoglycans (hyaluronic acid, chondroitin sulfate, heparan sulfate) attached to proteoglycan complexes within the extracellular matrix. Micronutrients reflect general organ tissue composition: iron (estimated 2-5 mg/100g wet weight from hemoglobin and myoglobin residues), zinc (2-4 mg/100g), and phosphorus (150-200 mg/100g). B vitamins are present at trace levels consistent with mammalian tissue, including B12 (estimated 0.5-1.5 µg/100g), riboflavin (B2, ~0.2-0.3 mg/100g), and niacin (B3, ~3-5 mg/100g). Bioactive compounds of theoretical relevance include uterine-specific signaling peptides, oxytocin receptor proteins, and prostaglandin-synthesizing enzymes (COX-1, COX-2), though these are largely denatured or degraded during standard extraction and processing procedures. Growth factors associated with uterine tissue (IGF-1, EGF, TGF-β) may be present in trace amounts in non-hydrolyzed extracts but concentrations are extraction-method-dependent and not standardized. Bioavailability of intact proteins is poor without hydrolysis; peptide fragments from partial hydrolysis may have improved intestinal absorption. Heavy metal contamination risk (cadmium, lead) exists as with all organ-derived extracts and is source-dependent. No standardized concentration data for bioactive peptides exists in peer-reviewed literature for this specific extract.

Preparation & Dosage

No clinically studied dosage ranges, forms, or standardization protocols exist for ovine uterus extract as no human trials have been conducted. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients identified due to lack of research

Safety & Interactions

Because no human trials exist, a comprehensive safety profile for ovine uterus extract has not been established in peer-reviewed literature. Theoretical risks include allergic reactions in individuals with sensitivities to sheep-derived animal products, as well as potential prion-disease transmission risk associated with ovine-sourced tissues if not properly screened and processed. Individuals taking hormone-modulating medications—such as estrogen therapies, progestins, or fertility drugs—should exercise caution given the extract's theoretical hormonal activity, and pregnant or breastfeeding women should avoid use entirely due to unknown effects. No drug interaction data exists, and no regulatory body has established an approved dosage or safety threshold.